Hostname: page-component-7479d7b7d-jwnkl Total loading time: 0 Render date: 2024-07-10T19:33:14.806Z Has data issue: false hasContentIssue false

1822 – Differences In Neurocognitive Functioning Between Healthy Controls, Delusional Disorder And Paranoid Schizophrenia

Published online by Cambridge University Press:  15 April 2020

A.T. Laorden
Affiliation:
Department of Psychiatry, Hospital General Universitario Gregorio Marañon, Madrid, Spain
I. Vicente
Affiliation:
Department of Psychiatry, Hospital General Universitario Gregorio Marañon, Madrid, Spain
M.J. Sánchez
Affiliation:
Department of Psychiatry, Hospital General Universitario Gregorio Marañon, Madrid, Spain
V. Del Amo
Affiliation:
Department of Psychiatry, Hospital General Universitario Gregorio Marañon, Madrid, Spain
I. García
Affiliation:
Department of Psychiatry, Hospital General Universitario Gregorio Marañon, Madrid, Spain
E. De Portugal
Affiliation:
Department of Psychiatry, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Since Kraepelin times, it is considered that the delusional disorder (DD) does not imply a cognitive deficit, unlike the paranoid schizophrenia (PS). However, empirical evidence is very limited.

Objective

To compare the neurocognitive functioning differences among healthy controls (HC), DD and PS patients.

Methods

Neurocognitive functioning was evaluated in 51 healthy controls, 69 DD patients and 41 PS patients (according to the SCID-I) using an extensive neuropsychological battery which evaluate five domains (attention, working memory, verbal memory, executive function and social cognition). Was performed multivariate analysis of covariance (ANCOVA) to compare differences in neuropsychological performance between the three groups. The potential confusion factors were controlled, like the socio-demographic characteristics, premorbid IQ (“National Adult Reading Test”), depressive symptoms (“Beck Depression Inventory”) and the positive and negative psychotic symptoms (“Positive and Negative Syndrome Scale”).

Results

DD patients showed a considerably worse neurocognitive functioning than healthy controls regarding to attention, verbal memory, executive functions and social cognition; while DD patients compared to PS only present a better neurocognitive performance in attention.

Conclusion

DD patients shown that neurocognitive deficit is relevant, unlike what it is considered since Kraepelin up to date, as shown in the DSM-IV-TR and the CIE-10.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.